Global and China Coronary Intervention Drug Eluting Stent Market Insights, Forecast to 2026

1.1 Coronary Intervention Drug Eluting Stent Product Introduction

1.2 Market Segments

1.3 Key Coronary Intervention Drug Eluting Stent Manufacturers Covered: Ranking by Revenue

1.4 Market by Type

1.4.1 Global Coronary Intervention Drug Eluting Stent Market Size Growth Rate by Type

1.4.2 Below 40 µm

1.4.3 40 µm- 65 µm

1.4.4 Above 65 µm

1.5 Market by Application

1.5.1 Global Coronary Intervention Drug Eluting Stent Market Size Growth Rate by Application

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Coronary Intervention Drug Eluting Stent Market Size, Estimates and Forecasts

2.1.1 Global Coronary Intervention Drug Eluting Stent Revenue 2015-2026

2.1.2 Global Coronary Intervention Drug Eluting Stent Sales 2015-2026

2.2 Global Coronary Intervention Drug Eluting Stent, Market Size by Producing Regions: 2015 VS 2020 VS 2026

2.3 Coronary Intervention Drug Eluting Stent Historical Market Size by Region (2015-2020)

2.3.1 Global Coronary Intervention Drug Eluting Stent Retrospective Market Scenario in Sales by Region: 2015-2020

2.3.2 Global Coronary Intervention Drug Eluting Stent Retrospective Market Scenario in Revenue by Region: 2015-2020

2.4 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Region (2021-2026)

2.4.1 Global Coronary Intervention Drug Eluting Stent Sales Forecast by Region (2021-2026)

2.4.2 Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Region (2021-2026)

3 Global Coronary Intervention Drug Eluting Stent Competitor Landscape by Players

3.1 Global Top Coronary Intervention Drug Eluting Stent Sales by Manufacturers

3.1.1 Global Coronary Intervention Drug Eluting Stent Sales by Manufacturers (2015-2020)

3.1.2 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Manufacturers (2015-2020)

3.2 Global Coronary Intervention Drug Eluting Stent Manufacturers by Revenue

3.2.1 Global Coronary Intervention Drug Eluting Stent Revenue by Manufacturers (2015-2020)

3.2.2 Global Coronary Intervention Drug Eluting Stent Revenue Share by Manufacturers (2015-2020)

3.2.3 Global Coronary Intervention Drug Eluting Stent Market Concentration Ratio (CR5 and HHI) (2015-2020)

3.2.4 Global Top 10 and Top 5 Companies by Coronary Intervention Drug Eluting Stent Revenue in 2019

3.2.5 Global Coronary Intervention Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Global Coronary Intervention Drug Eluting Stent Price by Manufacturers

3.4 Global Coronary Intervention Drug Eluting Stent Manufacturing Base Distribution, Product Types

3.4.1 Coronary Intervention Drug Eluting Stent Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Coronary Intervention Drug Eluting Stent Product Type

3.4.3 Date of International Manufacturers Enter into Coronary Intervention Drug Eluting Stent Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

4.1 Global Coronary Intervention Drug Eluting Stent Market Size by Type (2015-2020)

4.1.1 Global Coronary Intervention Drug Eluting Stent Sales by Type (2015-2020)

4.1.2 Global Coronary Intervention Drug Eluting Stent Revenue by Type (2015-2020)

4.1.3 Coronary Intervention Drug Eluting Stent Average Selling Price (ASP) by Type (2015-2026)

4.2 Global Coronary Intervention Drug Eluting Stent Market Size Forecast by Type (2021-2026)

4.2.1 Global Coronary Intervention Drug Eluting Stent Sales Forecast by Type (2021-2026)

4.2.2 Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Type (2021-2026)

4.2.3 Coronary Intervention Drug Eluting Stent Average Selling Price (ASP) Forecast by Type (2021-2026)

4.3 Global Coronary Intervention Drug Eluting Stent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

5.1 Global Coronary Intervention Drug Eluting Stent Market Size by Application (2015-2020)

5.1.1 Global Coronary Intervention Drug Eluting Stent Sales by Application (2015-2020)

5.1.2 Global Coronary Intervention Drug Eluting Stent Revenue by Application (2015-2020)

5.1.3 Coronary Intervention Drug Eluting Stent Price by Application (2015-2020)

5.2 Coronary Intervention Drug Eluting Stent Market Size Forecast by Application (2021-2026)

5.2.1 Global Coronary Intervention Drug Eluting Stent Sales Forecast by Application (2021-2026)

5.2.2 Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Application (2021-2026)

5.2.3 Global Coronary Intervention Drug Eluting Stent Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

6.1 China Coronary Intervention Drug Eluting Stent Market Size YoY Growth 2015-2026

6.1.1 China Coronary Intervention Drug Eluting Stent Sales YoY Growth 2015-2026

6.1.2 China Coronary Intervention Drug Eluting Stent Revenue YoY Growth 2015-2026

6.1.3 China Coronary Intervention Drug Eluting Stent Market Share in Global Market 2015-2026

6.2 China Coronary Intervention Drug Eluting Stent Market Size by Players (International and Local Players)

6.2.1 China Top Coronary Intervention Drug Eluting Stent Players by Sales (2015-2020)

6.2.2 China Top Coronary Intervention Drug Eluting Stent Players by Revenue (2015-2020)

6.3 China Coronary Intervention Drug Eluting Stent Historic Market Review by Type (2015-2020)

6.3.1 China Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2015-2020)

6.3.2 China Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2015-2020)

6.3.3 China Coronary Intervention Drug Eluting Stent Price by Type (2015-2020)

6.4 China Coronary Intervention Drug Eluting Stent Market Estimates and Forecasts by Type (2021-2026)

6.4.1 China Coronary Intervention Drug Eluting Stent Sales Forecast by Type (2021-2026)

6.4.2 China Coronary Intervention Drug Eluting Stent Revenue Forecast by Type (2021-2026)

6.4.3 China Coronary Intervention Drug Eluting Stent Price Forecast by Type (2021-2026)

6.5 China Coronary Intervention Drug Eluting Stent Historic Market Review by Application (2015-2020)

6.5.1 China Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2015-2020)

6.5.2 China Coronary Intervention Drug Eluting Stent Revenue Market Share by Application (2015-2020)

6.5.3 China Coronary Intervention Drug Eluting Stent Price by Application (2015-2020)

6.6 China Coronary Intervention Drug Eluting Stent Market Estimates and Forecasts by Application (2021-2026)

6.6.1 China Coronary Intervention Drug Eluting Stent Sales Forecast by Application (2021-2026)

6.6.2 China Coronary Intervention Drug Eluting Stent Revenue Forecast by Application (2021-2026)

6.6.3 China Coronary Intervention Drug Eluting Stent Price Forecast by Application (2021-2026)

7 North America

7.1 North America Coronary Intervention Drug Eluting Stent Market Size YoY Growth 2015-2026

7.2 North America Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country

7.2.1 North America Coronary Intervention Drug Eluting Stent Sales by Country (2015-2020)

7.2.2 North America Coronary Intervention Drug Eluting Stent Revenue by Country (2015-2020)

7.2.3 U.S.

7.2.4 Canada

8 Europe

8.1 Europe Coronary Intervention Drug Eluting Stent Market Size YoY Growth 2015-2026

8.2 Europe Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country

8.2.1 Europe Coronary Intervention Drug Eluting Stent Sales by Country

8.2.2 Europe Coronary Intervention Drug Eluting Stent Revenue by Country

8.2.3 Germany

8.2.4 France

8.2.5 U.K.

8.2.6 Italy

8.2.7 Russia

9 Asia Pacific

9.1 Asia Pacific Coronary Intervention Drug Eluting Stent Market Size YoY Growth 2015-2026

9.2 Asia Pacific Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country

9.2.1 Asia Pacific Coronary Intervention Drug Eluting Stent Sales by Region (2015-2020)

9.2.2 Asia Pacific Coronary Intervention Drug Eluting Stent Revenue by Region

9.2.3 China

9.2.4 Japan

9.2.5 South Korea

9.2.6 India

9.2.7 Australia

9.2.8 Taiwan

9.2.9 Indonesia

9.2.10 Thailand

9.2.11 Malaysia

9.2.12 Philippines

9.2.13 Vietnam

10 Latin America

10.1 Latin America Coronary Intervention Drug Eluting Stent Market Size YoY Growth 2015-2026

10.2 Latin America Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country

10.2.1 Latin America Coronary Intervention Drug Eluting Stent Sales by Country

10.2.2 Latin America Coronary Intervention Drug Eluting Stent Revenue by Country

10.2.3 Mexico

10.2.4 Brazil

10.2.5 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Coronary Intervention Drug Eluting Stent Market Size YoY Growth 2015-2026

11.2 Middle East and Africa Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country

11.2.1 Middle East and Africa Coronary Intervention Drug Eluting Stent Sales by Country

11.2.2 Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue by Country

11.2.3 Turkey

11.2.4 Saudi Arabia

11.2.5 U.A.E

12 Company Profiles

12.1 Synlas GmbH

12.1.1 Synlas GmbH Corporation Information

12.1.2 Synlas GmbH Description and Business Overview

12.1.3 Synlas GmbH Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Synlas GmbH Coronary Intervention Drug Eluting Stent Products Offered

12.1.5 Synlas GmbH Recent Development

12.2 YILSON

12.2.1 YILSON Corporation Information

12.2.2 YILSON Description and Business Overview

12.2.3 YILSON Sales, Revenue and Gross Margin (2015-2020)

12.2.4 YILSON Coronary Intervention Drug Eluting Stent Products Offered

12.2.5 YILSON Recent Development

12.3 BrosMed Medical

12.3.1 BrosMed Medical Corporation Information

12.3.2 BrosMed Medical Description and Business Overview

12.3.3 BrosMed Medical Sales, Revenue and Gross Margin (2015-2020)

12.3.4 BrosMed Medical Coronary Intervention Drug Eluting Stent Products Offered

12.3.5 BrosMed Medical Recent Development

12.4 SCITECH Medical

12.4.1 SCITECH Medical Corporation Information

12.4.2 SCITECH Medical Description and Business Overview

12.4.3 SCITECH Medical Sales, Revenue and Gross Margin (2015-2020)

12.4.4 SCITECH Medical Coronary Intervention Drug Eluting Stent Products Offered

12.4.5 SCITECH Medical Recent Development

12.5 Wellinq

12.5.1 Wellinq Corporation Information

12.5.2 Wellinq Description and Business Overview

12.5.3 Wellinq Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Wellinq Coronary Intervention Drug Eluting Stent Products Offered

12.5.5 Wellinq Recent Development

12.6 Degania Silicone

12.6.1 Degania Silicone Corporation Information

12.6.2 Degania Silicone Description and Business Overview

12.6.3 Degania Silicone Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Degania Silicone Coronary Intervention Drug Eluting Stent Products Offered

12.6.5 Degania Silicone Recent Development

12.7 Alvimedica

12.7.1 Alvimedica Corporation Information

12.7.2 Alvimedica Description and Business Overview

12.7.3 Alvimedica Sales, Revenue and Gross Margin (2015-2020)

12.7.4 Alvimedica Coronary Intervention Drug Eluting Stent Products Offered

12.7.5 Alvimedica Recent Development

12.8 Interventional Medical Device Solutions

12.8.1 Interventional Medical Device Solutions Corporation Information

12.8.2 Interventional Medical Device Solutions Description and Business Overview

12.8.3 Interventional Medical Device Solutions Sales, Revenue and Gross Margin (2015-2020)

12.8.4 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Products Offered

12.8.5 Interventional Medical Device Solutions Recent Development

12.9 Comed BV

12.9.1 Comed BV Corporation Information

12.9.2 Comed BV Description and Business Overview

12.9.3 Comed BV Sales, Revenue and Gross Margin (2015-2020)

12.9.4 Comed BV Coronary Intervention Drug Eluting Stent Products Offered

12.9.5 Comed BV Recent Development

12.10 iVascular

12.10.1 iVascular Corporation Information

12.10.2 iVascular Description and Business Overview

12.10.3 iVascular Sales, Revenue and Gross Margin (2015-2020)

12.10.4 iVascular Coronary Intervention Drug Eluting Stent Products Offered

12.10.5 iVascular Recent Development

12.11 Synlas GmbH

12.11.1 Synlas GmbH Corporation Information

12.11.2 Synlas GmbH Description and Business Overview

12.11.3 Synlas GmbH Sales, Revenue and Gross Margin (2015-2020)

12.11.4 Synlas GmbH Coronary Intervention Drug Eluting Stent Products Offered

12.11.5 Synlas GmbH Recent Development

12.12 Eurocor Tech GmbH

12.12.1 Eurocor Tech GmbH Corporation Information

12.12.2 Eurocor Tech GmbH Description and Business Overview

12.12.3 Eurocor Tech GmbH Sales, Revenue and Gross Margin (2015-2020)

12.12.4 Eurocor Tech GmbH Products Offered

12.12.5 Eurocor Tech GmbH Recent Development

12.13 OrbusNeich

12.13.1 OrbusNeich Corporation Information

12.13.2 OrbusNeich Description and Business Overview

12.13.3 OrbusNeich Sales, Revenue and Gross Margin (2015-2020)

12.13.4 OrbusNeich Products Offered

12.13.5 OrbusNeich Recent Development

12.14 Endocor GmbH

12.14.1 Endocor GmbH Corporation Information

12.14.2 Endocor GmbH Description and Business Overview

12.14.3 Endocor GmbH Sales, Revenue and Gross Margin (2015-2020)

12.14.4 Endocor GmbH Products Offered

12.14.5 Endocor GmbH Recent Development

12.15 Meril Life Sciences

12.15.1 Meril Life Sciences Corporation Information

12.15.2 Meril Life Sciences Description and Business Overview

12.15.3 Meril Life Sciences Sales, Revenue and Gross Margin (2015-2020)

12.15.4 Meril Life Sciences Products Offered

12.15.5 Meril Life Sciences Recent Development

12.16 Acrostak

12.16.1 Acrostak Corporation Information

12.16.2 Acrostak Description and Business Overview

12.16.3 Acrostak Sales, Revenue and Gross Margin (2015-2020)

12.16.4 Acrostak Products Offered

12.16.5 Acrostak Recent Development

12.17 Boston Scientific Corporation

12.17.1 Boston Scientific Corporation Corporation Information

12.17.2 Boston Scientific Corporation Description and Business Overview

12.17.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)

12.17.4 Boston Scientific Corporation Products Offered

12.17.5 Boston Scientific Corporation Recent Development

12.18 B. Braun

12.18.1 B. Braun Corporation Information

12.18.2 B. Braun Description and Business Overview

12.18.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)

12.18.4 B. Braun Products Offered

12.18.5 B. Braun Recent Development

12.19 Biotronik

12.19.1 Biotronik Corporation Information

12.19.2 Biotronik Description and Business Overview

12.19.3 Biotronik Sales, Revenue and Gross Margin (2015-2020)

12.19.4 Biotronik Products Offered

12.19.5 Biotronik Recent Development

12.20 Abbott

12.20.1 Abbott Corporation Information

12.20.2 Abbott Description and Business Overview

12.20.3 Abbott Sales, Revenue and Gross Margin (2015-2020)

12.20.4 Abbott Products Offered

12.20.5 Abbott Recent Development

12.21 MicroPort Medical Group

12.21.1 MicroPort Medical Group Corporation Information

12.21.2 MicroPort Medical Group Description and Business Overview

12.21.3 MicroPort Medical Group Sales, Revenue and Gross Margin (2015-2020)

12.21.4 MicroPort Medical Group Products Offered

12.21.5 MicroPort Medical Group Recent Development

12.22 Philips

12.22.1 Philips Corporation Information

12.22.2 Philips Description and Business Overview

12.22.3 Philips Sales, Revenue and Gross Margin (2015-2020)

12.22.4 Philips Products Offered

12.22.5 Philips Recent Development

12.23 Terumo Corporation

12.23.1 Terumo Corporation Corporation Information

12.23.2 Terumo Corporation Description and Business Overview

12.23.3 Terumo Corporation Sales, Revenue and Gross Margin (2015-2020)

12.23.4 Terumo Corporation Products Offered

12.23.5 Terumo Corporation Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Porter’s Five Forces Analysis

13.5 Primary Interviews with Key Coronary Intervention Drug Eluting Stent Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Coronary Intervention Drug Eluting Stent Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

Table 1. Coronary Intervention Drug Eluting Stent Market Segments

Table 2. Ranking of Global Top Coronary Intervention Drug Eluting Stent Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Coronary Intervention Drug Eluting Stent Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Below 40 µm

Table 5. Major Manufacturers of 40 µm- 65 µm

Table 6. Major Manufacturers of Above 65 µm

Table 7. Global Coronary Intervention Drug Eluting Stent Market Size Growth Rate by Application 2020-2026 (K Units)

Table 8. Global Coronary Intervention Drug Eluting Stent Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 9. Global Coronary Intervention Drug Eluting Stent Sales by Regions 2015-2020 (K Units)

Table 10. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Regions (2015-2020)

Table 11. Global Coronary Intervention Drug Eluting Stent Revenue by Regions 2015-2020 (US$ Million)

Table 12. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Region (2021-2026) (K Units)

Table 13. Global Coronary Intervention Drug Eluting Stent Sales by Manufacturers (2015-2020) (K Units)

Table 14. Global Coronary Intervention Drug Eluting Stent Sales Share by Manufacturers (2015-2020)

Table 15. Global Coronary Intervention Drug Eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 16. Global Coronary Intervention Drug Eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coronary Intervention Drug Eluting Stent as of 2019)

Table 17. Coronary Intervention Drug Eluting Stent Revenue by Manufacturers (2015-2020) (US$ Million)

Table 18. Coronary Intervention Drug Eluting Stent Revenue Share by Manufacturers (2015-2020)

Table 19. Key Manufacturers Coronary Intervention Drug Eluting Stent Price (2015-2020) (US$/Unit)

Table 20. Coronary Intervention Drug Eluting Stent Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Coronary Intervention Drug Eluting Stent Product Type

Table 22. Date of International Manufacturers Enter into Coronary Intervention Drug Eluting Stent Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. Global Coronary Intervention Drug Eluting Stent Sales by Type (2015-2020) (K Units)

Table 25. Global Coronary Intervention Drug Eluting Stent Sales Share by Type (2015-2020)

Table 26. Global Coronary Intervention Drug Eluting Stent Revenue by Type (2015-2020) (US$ Million)

Table 27. Global Coronary Intervention Drug Eluting Stent Revenue Share by Type (2015-2020)

Table 28. Coronary Intervention Drug Eluting Stent Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)

Table 29. Global Coronary Intervention Drug Eluting Stent Sales Share by Type (2021-2026)

Table 30. Global Coronary Intervention Drug Eluting Stent Sales by Application (2015-2020) (K Units)

Table 31. Global Coronary Intervention Drug Eluting Stent Sales Share by Application (2015-2020)

Table 32. Global Coronary Intervention Drug Eluting Stent Sales Share by Application (2021-2026)

Table 33. Global Coronary Intervention Drug Eluting Stent Sales Market Share Forecast by Application (2021-2026)

Table 34. Global Coronary Intervention Drug Eluting Stent Revenue by Application (2015-2020) (US$ Million)

Table 35. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Application (2021-2026)

Table 36. China Coronary Intervention Drug Eluting Stent Sales (K Units) of Key Companies (2015-2020)

Table 37. China Coronary Intervention Drug Eluting Stent Sales Share by Company (2015-2020)

Table 38. China Coronary Intervention Drug Eluting Stent Revenue (US$ Million) by Company (2015-2020)

Table 39. China Coronary Intervention Drug Eluting Stent Sales (K Units) by Type (2015-2020)

Table 40. China Coronary Intervention Drug Eluting Stent Sales Share by Type (2015-2020)

Table 41. China Coronary Intervention Drug Eluting Stent Revenue (US$ Million) Market Share by Type (2015-2020)

Table 42. China Coronary Intervention Drug Eluting Stent Price (K Units) by Type (2015-2020)

Table 43. China Coronary Intervention Drug Eluting Stent Sales (K Units) by Type (2021-2026)

Table 44. China Coronary Intervention Drug Eluting Stent Sales Share by Type (2021-2026)

Table 45. China Coronary Intervention Drug Eluting Stent Revenue (US$ Million) Market Share by Type (2021-2026)

Table 46. China Coronary Intervention Drug Eluting Stent Revenue Share by Type (2021-2026)

Table 47. China Coronary Intervention Drug Eluting Stent Price (K Units) by Type (2021-2026)

Table 48. China Coronary Intervention Drug Eluting Stent Sales (K Units) by Application (2015-2020)

Table 49. China Coronary Intervention Drug Eluting Stent Sales Share by Application (2015-2020)

Table 50. China Coronary Intervention Drug Eluting Stent Revenue (US$ Million) Market Share by Application (2015-2020)

Table 51. China Coronary Intervention Drug Eluting Stent Sales (K Units) by Application (2021-2026)

Table 52. China Coronary Intervention Drug Eluting Stent Sales Share by Application (2021-2026)

Table 53. China Coronary Intervention Drug Eluting Stent Revenue (US$ Million) Market Share by Application (2021-2026)

Table 54. China Coronary Intervention Drug Eluting Stent Revenue Share by Application (2021-2026)

Table 55. North America Coronary Intervention Drug Eluting Stent Sales by Country (2015-2020) (K Units)

Table 56. North America Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2015-2020)

Table 57. North America Coronary Intervention Drug Eluting Stent Revenue by Country (2015-2020) (US$ Million)

Table 58. North America Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2015-2020)

Table 59. Europe Coronary Intervention Drug Eluting Stent Sales by Country (2015-2020) (K Units)

Table 60. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2015-2020)

Table 61. Europe Coronary Intervention Drug Eluting Stent Revenue by Country (2015-2020) (US$ Million)

Table 62. Europe Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2015-2020)

Table 63. Asia Pacific Coronary Intervention Drug Eluting Stent Sales by Region (2015-2020) (K Units)

Table 64. Asia Pacific Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2015-2020)

Table 65. Asia Pacific Coronary Intervention Drug Eluting Stent Revenue by Region (2015-2020) (US$ Million)

Table 66. Asia Pacific Coronary Intervention Drug Eluting Stent Revenue Market Share by Region (2015-2020)

Table 67. Latin America Coronary Intervention Drug Eluting Stent Sales by Country (2015-2020) (K Units)

Table 68. Latin America Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2015-2020)

Table 69. Latin Americaa Coronary Intervention Drug Eluting Stent Revenue by Country (2015-2020) (US$ Million)

Table 70. Latin America Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2015-2020)

Table 71. Middle East and Africa Coronary Intervention Drug Eluting Stent Sales by Country (2015-2020) (K Units)

Table 72. Middle East and Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2015-2020)

Table 73. Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue by Country (2015-2020) (US$ Million)

Table 74. Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2015-2020)

Table 75. Synlas GmbH Corporation Information

Table 76. Synlas GmbH Description and Business Overview

Table 77. Synlas GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 78. Synlas GmbH Coronary Intervention Drug Eluting Stent Product

Table 79. Synlas GmbH Recent Development

Table 80. YILSON Corporation Information

Table 81. YILSON Description and Business Overview

Table 82. YILSON Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 83. YILSON Product

Table 84. YILSON Recent Development

Table 85. BrosMed Medical Corporation Information

Table 86. BrosMed Medical Description and Business Overview

Table 87. BrosMed Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 88. BrosMed Medical Product

Table 89. BrosMed Medical Recent Development

Table 90. SCITECH Medical Corporation Information

Table 91. SCITECH Medical Description and Business Overview

Table 92. SCITECH Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 93. SCITECH Medical Product

Table 94. SCITECH Medical Recent Development

Table 95. Wellinq Corporation Information

Table 96. Wellinq Description and Business Overview

Table 97. Wellinq Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 98. Wellinq Product

Table 99. Wellinq Recent Development

Table 100. Degania Silicone Corporation Information

Table 101. Degania Silicone Description and Business Overview

Table 102. Degania Silicone Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 103. Degania Silicone Product

Table 104. Degania Silicone Recent Development

Table 105. Alvimedica Corporation Information

Table 106. Alvimedica Description and Business Overview

Table 107. Alvimedica Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 108. Alvimedica Product

Table 109. Alvimedica Recent Development

Table 110. Interventional Medical Device Solutions Corporation Information

Table 111. Interventional Medical Device Solutions Description and Business Overview

Table 112. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 113. Interventional Medical Device Solutions Product

Table 114. Interventional Medical Device Solutions Recent Development

Table 115. Comed BV Corporation Information

Table 116. Comed BV Description and Business Overview

Table 117. Comed BV Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 118. Comed BV Product

Table 119. Comed BV Recent Development

Table 120. iVascular Corporation Information

Table 121. iVascular Description and Business Overview

Table 122. iVascular Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 123. iVascular Product

Table 124. iVascular Recent Development

Table 125. LEPU Medical Corporation Information

Table 126. LEPU Medical Description and Business Overview

Table 127. LEPU Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 128. LEPU Medical Product

Table 129. LEPU Medical Recent Development

Table 130. Eurocor Tech GmbH Corporation Information

Table 131. Eurocor Tech GmbH Description and Business Overview

Table 132. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 133. Eurocor Tech GmbH Product

Table 134. Eurocor Tech GmbH Recent Development

Table 135. OrbusNeich Corporation Information

Table 136. OrbusNeich Description and Business Overview

Table 137. OrbusNeich Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 138. OrbusNeich Product

Table 139. OrbusNeich Recent Development

Table 140. Endocor GmbH Corporation Information

Table 141. Endocor GmbH Description and Business Overview

Table 142. Endocor GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 143. Endocor GmbH Product

Table 144. Endocor GmbH Recent Development

Table 145. Meril Life Sciences Corporation Information

Table 146. Meril Life Sciences Description and Business Overview

Table 147. Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 148. Meril Life Sciences Product

Table 149. Meril Life Sciences Recent Development

Table 150. Acrostak Corporation Information

Table 151. Acrostak Description and Business Overview

Table 152. Acrostak Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 153. Acrostak Product

Table 154. Acrostak Recent Development

Table 155. Boston Scientific Corporation Corporation Information

Table 156. Boston Scientific Corporation Description and Business Overview

Table 157. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 158. Boston Scientific Corporation Product

Table 159. Boston Scientific Corporation Recent Development

Table 160. B. Braun Corporation Information

Table 161. B. Braun Description and Business Overview

Table 162. B. Braun Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 163. B. Braun Product

Table 164. B. Braun Recent Development

Table 165. Biotronik Corporation Information

Table 166. Biotronik Description and Business Overview

Table 167. Biotronik Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 168. Biotronik Product

Table 169. Biotronik Recent Development

Table 170. Abbott Corporation Information

Table 171. Abbott Description and Business Overview

Table 172. Abbott Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 173. Abbott Product

Table 174. Abbott Recent Development

Table 175. MicroPort Medical Group Corporation Information

Table 176. MicroPort Medical Group Description and Business Overview

Table 177. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 178. MicroPort Medical Group Product

Table 179. MicroPort Medical Group Recent Development

Table 180. Philips Corporation Information

Table 181. Philips Description and Business Overview

Table 182. Philips Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 183. Philips Product

Table 184. Philips Recent Development

Table 185. Terumo Corporation Corporation Information

Table 186. Terumo Corporation Description and Business Overview

Table 187. Terumo Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)

Table 188. Terumo Corporation Product

Table 189. Terumo Corporation Recent Development

Table 190. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 191. Key Challenges

Table 192. Market Risks

Table 193. Main Points Interviewed from Key Coronary Intervention Drug Eluting Stent Players

Table 194. Coronary Intervention Drug Eluting Stent Customers List

Table 195. Coronary Intervention Drug Eluting Stent Distributors List

Table 196. Research Programs/Design for This Report

Table 197. Key Data Information from Secondary Sources

Table 198. Key Data Information from Primary Sources

List of Figures

Figure 1. Coronary Intervention Drug Eluting Stent Product Picture

Figure 2. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020 & 2026

Figure 3. Below 40 µm Product Picture

Figure 4. 40 µm- 65 µm Product Picture

Figure 5. Above 65 µm Product Picture

Figure 6. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020 & 2026

Figure 7. Hospital

Figure 8. Clinic

Figure 9. Others

Figure 10. Coronary Intervention Drug Eluting Stent Report Years Considered

Figure 11. Global Coronary Intervention Drug Eluting Stent Market Size 2015-2026 (US$ Million)

Figure 12. Global Coronary Intervention Drug Eluting Stent Sales 2015-2026 (K Units)

Figure 13. Global Coronary Intervention Drug Eluting Stent Market Size Market Share by Region: 2020 Versus 2026

Figure 14. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2015-2020)

Figure 15. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Region in 2019

Figure 16. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Region (2015-2020)

Figure 17. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Region in 2019

Figure 18. Global Coronary Intervention Drug Eluting Stent Sales Share by Manufacturer in 2019

Figure 19. The Top 10 and 5 Players Market Share by Coronary Intervention Drug Eluting Stent Revenue in 2019

Figure 20. Coronary Intervention Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2015-2020)

Figure 22. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2019

Figure 23. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2015-2020)

Figure 24. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type in 2019

Figure 25. Global Coronary Intervention Drug Eluting Stent Market Share by Price Range (2015-2020)

Figure 26. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2015-2020)

Figure 27. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2019

Figure 28. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application (2015-2020)

Figure 29. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application in 2019

Figure 30. China Coronary Intervention Drug Eluting Stent Sales Growth Rate 2015-2026 (K Units)

Figure 31. China Coronary Intervention Drug Eluting Stent Revenue Growth Rate 2015-2026 (US$ Million)

Figure 32. China Coronary Intervention Drug Eluting Stent Market Share in Global Market 2015-2026

Figure 33. China 5 and 10 Largest Coronary Intervention Drug Eluting Stent Players Market Share by Revenue in Coronary Intervention Drug Eluting Stent in 2019

Figure 34. China Coronary Intervention Drug Eluting Stent Revenue Share by Type (2015-2020)

Figure 35. China Coronary Intervention Drug Eluting Stent Revenue Growth Rate by Type in 2015 & 2019

Figure 36. China Coronary Intervention Drug Eluting Stent Revenue Share by Application (2015-2020)

Figure 37. China Coronary Intervention Drug Eluting Stent Revenue Growth Rate by Application in 2015 & 2019

Figure 38. North America Coronary Intervention Drug Eluting Stent Sales Growth Rate 2015-2020 (K Units)

Figure 39. North America Coronary Intervention Drug Eluting Stent Revenue Growth Rate 2015-2020 (US$ Million)

Figure 40. North America Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2019

Figure 41. North America Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2019

Figure 42. U.S. Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 43. U.S. Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. Canada Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 45. Canada Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. Europe Coronary Intervention Drug Eluting Stent Sales Growth Rate 2015-2020 (K Units)

Figure 47. Europe Coronary Intervention Drug Eluting Stent Revenue Growth Rate 2015-2020 (US$ Million)

Figure 48. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2019

Figure 49. Europe Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2019

Figure 50. Germany Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 51. Germany Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. France Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 53. France Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. U.K. Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 55. U.K. Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Italy Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 57. Italy Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Russia Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 59. Russia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Asia Pacific Coronary Intervention Drug Eluting Stent Sales Growth Rate 2015-2020 (K Units)

Figure 61. Asia Pacific Coronary Intervention Drug Eluting Stent Revenue Growth Rate 2015-2020 (US$ Million)

Figure 62. Asia Pacific Coronary Intervention Drug Eluting Stent Sales Market Share by Region in 2019

Figure 63. Asia Pacific Coronary Intervention Drug Eluting Stent Revenue Market Share by Region in 2019

Figure 64. China Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 65. China Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Japan Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 67. Japan Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. South Korea Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 69. South Korea Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. India Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 71. India Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Australia Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 73. Australia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Taiwan Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 75. Taiwan Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Indonesia Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 77. Indonesia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Thailand Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 79. Thailand Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Malaysia Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 81. Malaysia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Philippines Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 83. Philippines Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Vietnam Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 85. Vietnam Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Latin America Coronary Intervention Drug Eluting Stent Sales Growth Rate 2015-2020 (K Units)

Figure 87. Latin America Coronary Intervention Drug Eluting Stent Revenue Growth Rate 2015-2020 (US$ Million)

Figure 88. Latin America Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2019

Figure 89. Latin America Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2019

Figure 90. Mexico Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 91. Mexico Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Brazil Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 93. Brazil Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Argentina Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 95. Argentina Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Middle East and Africa Coronary Intervention Drug Eluting Stent Sales Growth Rate 2015-2020 (K Units)

Figure 97. Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue Growth Rate 2015-2020 (US$ Million)

Figure 98. Middle East and Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2019

Figure 99. Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2019

Figure 100. Turkey Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 101. Turkey Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 102. Saudi Arabia Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 103. Saudi Arabia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. U.A.E Coronary Intervention Drug Eluting Stent Sales Growth Rate (2015-2020) (K Units)

Figure 105. U.A.E Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Porter's Five Forces Analysis

Figure 107. Coronary Intervention Drug Eluting Stent Value Chain

Figure 108. Channels of Distribution

Figure 109. Distributors Profiles

Figure 110. Bottom-up and Top-down Approaches for This Report

Figure 111. Data Triangulation

Figure 112. Key Executives Interviewed